Kissei Pharmaceutical Co., Ltd. (TYO:4547)

Kissei Pharmaceutical Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Kissei Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥4,483. The average 1-year stock price forecast is 15.40% higher than the current stock price, while the lowest is ¥4,000 (+2.96%) and the highest is ¥5,500 (+41.57%).

Price Target: ¥4,483 (+15.40%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	¥4,000	¥4,483	¥4,250	¥5,500
Change	+2.96%	+15.40%	+9.40%	+41.57%

Analyst Ratings

The average analyst rating for Kissei Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26	Nov '26
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	0	0	0
Hold	3	3	3	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst UBS No rating	UBS	Hold Maintains ¥4,400	Hold	Maintains	¥4,400	+13.26%	Oct 28, 2026
Unknown Analyst Daiwa No rating	Daiwa	Hold Maintains ¥4,000	Hold	Maintains	¥4,000	+2.96%	Sep 28, 2026
Unknown Analyst Mizuho Securities No rating	Mizuho Securities	Hold Maintains ¥4,200 → ¥4,100	Hold	Maintains	¥4,200 → ¥4,100	+5.53%	Sep 17, 2026
Unknown Analyst Nomura No rating	Nomura	Hold Downgrades ¥5,600 → ¥4,100	Hold	Downgrades	¥5,600 → ¥4,100	+5.53%	Jun 5, 2026
Unknown Analyst SBI Securities No rating	SBI Securities	Hold Maintains ¥3,760	Hold	Maintains	¥3,760	-3.22%	Jun 4, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

92.64B

Decreased by -4.89%

from 97.41B

Revenue Next Year

91.35B

Decreased by -1.39%

from 92.64B

EPS This Year

298.80

Decreased by -9.87%

from 331.53

EPS Next Year

200.93

Decreased by -32.75%

from 298.80

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	65.38B	67.49B	75.58B	88.33B	97.41B	92.64B
Revenue Growth	-5.31%	3.23%	11.98%	16.87%	10.28%	-4.89%
Gross Profit	31.24B	32.38B	37.34B	44.07B	45.82B	44.30B
Gross Margin	47.78%	47.97%	49.41%	49.89%	47.04%	47.82%
Operating Income	-1.40B	-1.14B	4.02B	5.77B	-2.93B	1.96B
Net Income	12.92B	10.53B	11.16B	11.96B	13.78B	12.39B
EPS	280.19	228.30	246.58	274.20	331.53	298.80
EPS Growth	147.41%	-18.52%	8.01%	11.20%	20.91%	-9.87%
Forward PE	36.67	10.90	14.26	17.88	15.06	13.00
Dividend / Share	56.00	80.00	82.00	100.00	120.00	170.00
Dividend Growth	3.70%	42.86%	2.50%	21.95%	20.00%	41.67%
Free Cash Flow	-	-	-	-	-7.94B	10.80B
No. Analysts	-	-	-	-	-	4

Financial currency is JPY.

Revenue Forecast

Chart

Revenue	2027	2028	2029
High	98.2B
Avg	92.6B
Low	89.3B

Revenue Growth

Chart

Revenue Growth	2027	2028	2029
High	0.8%
Avg	-4.9%
Low	-8.3%

EPS Forecast

Chart

EPS	2027	2028	2029
High	362.60
Avg	298.80
Low	260.16

EPS Growth

EPS Growth	2027	2028	2029
High	9.4%
Avg	-9.9%
Low	-21.5%

Data Sources: S&P Global Market Intelligence and TipRanks Last updated: Oct 28, 2026

Price targets, consensus ratings and financial forecasts are provided by S&P Global Market Intelligence. Individual analyst data is provided by TipRanks. Price targets and consensus ratings update every hour to every three days, while individual analyst data updates in near real-time.

Data Sources Report a data error